On December 19, 2022, the Board of Directors of MacroGenics, Inc. approved the appointment of Margaret Liu, M.D. to serve as a director on the Board, effective January 3, 2023 (the âEffective Dateâ). Dr. Liu has been designated as a Class II director to hold office until the Companyâs 2024 Annual Meeting of Stockholders, or until her successor has been duly elected and qualified, or until her earlier death, resignation or removal. Dr. Liu has been appointed to the Science & Technology Committee, effective as of the Effective Date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.55 USD | -1.73% | +4.24% | -52.70% |
05-10 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
05-10 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.70% | 285M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- MGNX Stock
- News MacroGenics, Inc.
- Macrogenics, Inc. Approves the Appointment of Margaret Liu, M.D. to Serve as Director